您的购物车当前为空
别名 金妥利珠单抗, Gentulizumab, Gensci-059
Gentulizumab (Gensci-059) 是人源化IgG4抗体,特异性结合CD47。在人和猴子体内,Gentulizumab 展示出与CD47的高亲和力,有效抑制CD47-SIRPα相互作用,并表现出显著的抗肿瘤活性。Gentulizumab 的同型对照可参考 HumanIgG4(S228P) kappa, Isotype Control。
Gentulizumab (Gensci-059) 是人源化IgG4抗体,特异性结合CD47。在人和猴子体内,Gentulizumab 展示出与CD47的高亲和力,有效抑制CD47-SIRPα相互作用,并表现出显著的抗肿瘤活性。Gentulizumab 的同型对照可参考 HumanIgG4(S228P) kappa, Isotype Control。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | 待询 | 待询 | |
| 5 mg | 待询 | 待询 |
| 产品描述 | Gentulizumab (Gensci-059) is a humanized IgG4 antibody that targets and binds to CD47. It demonstrates strong binding affinity to CD47 in both humans and monkeys and effectively inhibits the interaction between CD47 and SIRPα. Gentulizumab exhibits potent antitumor activity. For isotype control, refer to HumanIgG4(S228P) kappa, Isotype Control. |
| 别名 | 金妥利珠单抗, Gentulizumab, Gensci-059 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
评论内容